AHSAN RIZVI to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications AHSAN RIZVI has written about Xenograft Model Antitumor Assays.
Connection Strength
0.031
-
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer. Clin Cancer Res. 2020 01 01; 26(1):242-255.
Score: 0.031
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.